113 related articles for article (PubMed ID: 18436887)
1. Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density.
Li JM; Mogi M; Iwanami J; Min LJ; Tsukuda K; Sakata A; Fujita T; Iwai M; Horiuchi M
Stroke; 2008 Jul; 39(7):2029-36. PubMed ID: 18436887
[TBL] [Abstract][Full Text] [Related]
2. Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Inaba S; Iwai M; Tomono Y; Senba I; Furuno M; Kanno H; Okayama H; Mogi M; Higaki J; Horiuchi M
Stroke; 2009 Feb; 40(2):597-603. PubMed ID: 19023100
[TBL] [Abstract][Full Text] [Related]
3. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
[TBL] [Abstract][Full Text] [Related]
4. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice.
Iwanami J; Mogi M; Li JM; Tsukuda K; Min LJ; Sakata A; Fujita T; Iwai M; Horiuchi M
Stroke; 2008 Sep; 39(9):2554-9. PubMed ID: 18617657
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage.
Bai HY; Mogi M; Nakaoka H; Kan-No H; Tsukuda K; Chisaka T; Wang XL; Kukida M; Shan BS; Yamauchi T; Higaki A; Iwanami J; Horiuchi M
Eur J Pharmacol; 2015 Sep; 762():293-8. PubMed ID: 26057694
[TBL] [Abstract][Full Text] [Related]
8. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.
Min LJ; Mogi M; Tsukuda K; Jing F; Ohshima K; Nakaoka H; Kan-No H; Wang XL; Chisaka T; Bai HY; Iwanami J; Horiuchi M
Am J Hypertens; 2014 Aug; 27(8):1036-44. PubMed ID: 24572705
[TBL] [Abstract][Full Text] [Related]
9. Effects of valsartan on neuroprotection and neurogenesis after ischemia.
Wakai T; Yoshioka H; Yagi T; Kato T; Kinouchi H
Neuroreport; 2011 Jun; 22(8):385-90. PubMed ID: 21494160
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
11. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2.
Mogi M; Li JM; Iwanami J; Min LJ; Tsukuda K; Iwai M; Horiuchi M
Hypertension; 2006 Jul; 48(1):141-8. PubMed ID: 16769992
[TBL] [Abstract][Full Text] [Related]
14. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
15. Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism.
van der Zijl NJ; Serné EH; Goossens GH; Moors CC; Ijzerman RG; Blaak EE; Diamant M
J Hypertens; 2011 Oct; 29(10):1955-62. PubMed ID: 21844821
[TBL] [Abstract][Full Text] [Related]
16. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.
Wu L; Iwai M; Nakagami H; Li Z; Chen R; Suzuki J; Akishita M; de Gasparo M; Horiuchi M
Circulation; 2001 Nov; 104(22):2716-21. PubMed ID: 11723025
[TBL] [Abstract][Full Text] [Related]
17. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
18. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ
Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M
Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425
[TBL] [Abstract][Full Text] [Related]
20. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
